Renaissance Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Renaissance Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,970	Closed	-$295K	–	301
2015 Q2	$295K	Sell	6,970 -356,091	-98%	-$15M	0.01%	207
2015 Q1	$14.1M	Sell	363,061 -36,005	-9%	-$1.39M	0.53%	73
2014 Q4	$13.4M	Sell	399,066 -8,442	-2%	-$298K	0.52%	73
2014 Q3	$14.3M	Buy	407,508 +33,588	+9%	+$1.15M	0.56%	62
2014 Q2	$12.3M	Buy	373,920 +24,886	+7%	+$852K	0.47%	99
2014 Q1	$12.9M	Sell	349,034 -190,429	-35%	-$6.99M	0.51%	88
2013 Q4	$20.7M	Sell	539,463 -88,350	-14%	-$2.79M	0.84%	56
2013 Q3	$17.2M	Sell	627,813 -36,151	-5%	-$857K	0.73%	56
2013 Q2	$13.9M	Buy	+663,964	New	+$13M	0.63%	59

Other funds holding WX

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Renaissance Group's WX Position: Q3 2015 in Review

Renaissance Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 6,970 shares — an estimated $295K sold.

Renaissance Group first reported a position in WX in Q2 2013 and held it in 9 quarters. The position peaked at $20.7M in Q4 2013. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

Renaissance Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
Renaissance Group sold 6,970 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $295K.
Renaissance Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 9 quarters.
Renaissance Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $20.7M in Q4 2013.
151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Renaissance Group's 13F filing for Q3 2015, filed 5 Nov 2015.